Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer,s Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?

Publisher: Bentham Science Publishers

E-ISSN: 1875-5828|13|4|403-412

ISSN: 1567-2050

Source: Current Alzheimer Research, Vol.13, Iss.4, 2016-04, pp. : 403-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content